Brooks Moore & Associates’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$309K Hold
7,144
0.17% 92
2025
Q1
$436K Hold
7,144
0.25% 76
2024
Q4
$404K Hold
7,144
0.24% 73
2024
Q3
$370K Sell
7,144
-15
-0.2% -$776 0.22% 72
2024
Q2
$297K Hold
7,159
0.19% 75
2024
Q1
$388K Hold
7,159
0.25% 69
2023
Q4
$367K Hold
7,159
0.25% 67
2023
Q3
$416K Sell
7,159
-7,615
-52% -$442K 0.31% 62
2023
Q2
$945K Sell
14,774
-470
-3% -$30.1K 0.67% 47
2023
Q1
$1.06M Buy
15,244
+845
+6% +$58.6K 0.76% 41
2022
Q4
$1.04M Buy
14,399
+425
+3% +$30.6K 0.76% 41
2022
Q3
$993K Hold
13,974
0.8% 41
2022
Q2
$1.08M Hold
13,974
0.78% 42
2022
Q1
$1.02M Sell
13,974
-925
-6% -$67.6K 0.63% 48
2021
Q4
$929K Sell
14,899
-14,980
-50% -$934K 0.54% 47
2021
Q3
$1.77M Buy
29,879
+168
+0.6% +$9.94K 1.16% 36
2021
Q2
$1.99M Buy
29,711
+4,600
+18% +$307K 1.27% 34
2021
Q1
$1.59M Buy
25,111
+836
+3% +$52.8K 1.07% 38
2020
Q4
$1.51M Buy
24,275
+700
+3% +$43.4K 1.17% 36
2020
Q3
$1.42M Buy
23,575
+1,890
+9% +$114K 1.23% 34
2020
Q2
$1.28M Buy
21,685
+4,222
+24% +$248K 1.19% 31
2020
Q1
$973K Buy
17,463
+1,770
+11% +$98.6K 1.03% 37
2019
Q4
$1.01M Sell
15,693
-2,545
-14% -$163K 0.8% 43
2019
Q3
$925K Buy
18,238
+3,225
+21% +$164K 0.78% 47
2019
Q2
$681K Buy
15,013
+740
+5% +$33.6K 0.58% 61
2019
Q1
$681K Hold
14,273
0.62% 54
2018
Q4
$742K Buy
+14,273
New +$742K 0.75% 51